The tolerability and efficacy of simeprevir in combination with peginterferon and ribavirin in patients infected with hepatitis C virus (HCV) genotype 1 under actual clinical conditions were investigated.
Authors:
Takao Watanabe, Kouji Joko, Hirotaka Seike, Kojiro Michitaka, Norio Horiike, Yoshiyasu Kisaka, Yoshinori Tanaka, Seiji Nakanishi, Kimio Nakanishi, Takashi Nonaka, Kazuhiko Yamauchi, Morikazu Onji, Yoshinori Ohno, Yoshio Tokumoto, Masashi Hirooka, Masanori Abe…
Citation:
SpringerPlus
2016
5:518
Content type: Research
Published on: 26 April 2016